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Editorial on the Research Topic
Macrophage Metabolism and Immune Responses
Macrophages are key components of the immune response to infectious organisms, with a dual
role eliminating infectious agents by phagocytosis while mediating defensive and inflammatory
pathways. On the other hand, macrophages are also involved in the late response to infections by
heavily contributing to tissue debris clearance and “wound” repair. The importance of themetabolic
status of these immune cells on their responses has been overlooked for decades. However, recent
advances in metagenomics and high-throughput metabolic profiling have partially unveiled the
role of metabolism in macrophage responses. New evidence suggests that the metabolic status
and specific metabolic pathways are instrumental for the modulation of macrophage responses to
the ever-changing environment that these cells face in vivo. For example, a role of metabolism in
reactive oxygen species production in response to pathogens has been long known. Furthermore,
macrophage transition from an anti to a pro-inflammatory phenotype seems to be at least partially
mediated metabolic reprogramming from fatty acid oxidation to glycolysis. Recent studies have
also shown metabolic plasticity during long-term responses to vaccine formulations of individual
pathogen-associated molecular patterns. The capacity of macrophages to be trained, an emerging
concept describing the “learning” capacity of innate immune cells, seems to be also underpinned
by metabolic switches. This Research Topic aims to shed light on our current understanding of
the role of metabolism in macrophage biology and versatility focusing on the immune response to
infectious agents.
Two of the articles in the topic are specifically dedicated to the role of macrophage metabolism
during infection. In a review, Ramond et al., discuss the ability of some bacterial pathogens to
manipulatemacrophagemetabolic programs to survive intracellularly and howmitochondria could
play a paramount role by regulating cellular metabolism and immune responses against these
pathogens. Although studies addressing this interplay need further refinement to reflect in vivo
conditions, they encourage the implementation of host-directed therapies for clinical infections
where manipulation of metabolic responses through this organelle can help to resolve infections.
More specifically, to clarify the observed susceptibility to infection of bone marrow macrophages
(BMMs) from CBA mice by two species of Leishmania, Bezerra de Menezes et al., performed a
differential proteomic analysis of infected macrophages and found that host responses related to
oxidative stress and iron metabolism might dictate the intracellular fate of this pathogen.
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Different articles in the topic are focused on the importance
of metabolic adjustments for macrophage activation. In a review
by Diaz-Bulnes et al., the authors address the phenomenon
of metabolic rewiring in macrophage activation, and how
those metabolic modifications allow those cells to adapt to
changes in the environment (such as hypoxia or oxidative
stress) maintaining their pro-inflammatory and anti-microbial
activities. This response is coordinated by different metabolic
mechanisms. In this review, they illustrate the relation of the
metabolic and phenotypic plasticity ofmacrophages with hypoxia
and endoplasmic reticulum stress, and how they can relate
to human pathology and chronic inflammation. Two different
reviews in the topic summarized, using different point of views,
the relevance of macrophage metabolic activation with the
focus on metabolic disease. Daemen and Schilling, highlight
the multiple and relevant connections between obesity and
macrophage metabolic activation. The article initially covers
macrophage dynamics and diversity in liver and adipose tissue,
both crucial areas for the study of metabolic diseases. The
review also summarizes the available knowledge regarding the
role of macrophage metabolic regulation for metabolic diseases
and, in particular, obesity, also addressing the importance
of niche determinants for this metabolic tuning and for the
overall function of macrophages. Furthermore, Daemen and
Schilling describe future challenges in the topic and suggest
new therapeutic possibilities based on macrophage targeting
in order to treat metabolic disorders. Meanwhile, the role
of lipids in the metabolic reprogramming of macrophages
is reviewed by Batista-Gonzalez et al.. They summarize the
available knowledge regarding the role of lipids in macrophage
plasticity from the importance of the differential fatty acid
metabolism in the dichotomic, in vitro endorsed, M1 (pro-
inflammatory) to M2 (anti-inflammatory) transition, down to
the role of lipids on macrophage activation. In this review, the
authors summarize new research challenging the old consensus
that defines M1 as aerobic glycolytic cells and fatty acid
oxidation as characteristic of M2 macrophages suggesting a
more dynamic metabolic reprogramming. Finally, they suggest
possible therapeutic interventions targeting lipid metabolism
in order to prevent the activation of macrophages. Also in
relation to lipids, original research by Sohrabi et al., highlight
the relationship of trained innate immune responses to the
reprogramming of different cellular metabolic pathways like
those related to the synthesis of cholesterol and fatty acids.
It is specifically explored the role of Liver Receptor X
(LXR), a key regulator of these pathways, whose activation
promotes a proinflammatory trained immunity phenotype in
human monocytes.
In an original research article focused on the interface
of nutrition and macrophage activation, Erkelens et al.
experimentally confirmed previous observations of the effect
of Vitamin A in the modulation of inflammation within the
gut. In particular, they showed that the vitamin favors the
anti-inflammatory state of intestinal tissue resident macrophages
within the gut. Furthermore, the article shows that Vitamin
A increases Dectin-A expression levels in macrophages under
homeostatic conditions. The authors further show that Dectin-
A induction provokes the release of pro-inflammatory cytokines
by macrophages. Based on these results, Erkelens et al. suggest
that Dectin-A-induced signaling might provide a switch from
an anti-inflammatory to a pro-inflammatory state of the
macrophage when needed. Finally, another original research
article is presented by Yang and Ding, demonstrating that
MEK1/2 inhibitors unravel the interferon response via interferon
regulatory factor 1 (Irf1) signaling in macrophages. They
pinpoint a deficiency in Irf1 that abolishes the interferon
response and prevents macrophages from reprogramming into
an immunostimulatory phenotype. A MEK1/2 inhibitor enables
IRF1-mediated interferon signature response in macrophages,
while a combination of inhibitor and agonist of Irf1 have
potential as therapy.
The manuscripts included in this Special Issue highlight
and expand our understanding of the adaptative capacity
of innate immune cells in response to inflammatory
signals and pinpoint the critical importance that metabolic
rearrangements play in the response kinetics of these first
responders of the immune system. They also highlight the
variability and intricacies of these metabolic adaptations,
shedding light into novel targets of intervention in order
to fine tune the response of macrophages to different
pathological conditions.
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